Prevention by DV-7028, a selective 5-HT2 receptor antagonist, of the formation of coronary thrombi in dogs

Publisher Website
Google Scholar
Abstract
Study objective — The aim was to determine the role of 5-HT derived from activated platelets in the formation of intracoronary thrombi in dogs. Design — Canine coronary thrombi were produced by inserting a small catheter filled with collagen powder into the endothelial-injured partially occluded left anterior descending coronary artery. The effects of intravenous DV-7028, a selective 5-HT2 receptor antagonist (bolus of 0.1 mg·kg−1, followed by 0.3 mg·kg−1·h−1 by infusion), and intravenous aspirin (1 mg·kg−1, followed by 3 mg·kg−1·h−1) in this experimental thrombus model were examined. Subjects — 43 dogs of either sex were used. In experiment A, DV-7028 (n = 12) or saline (n = 11) was given. In experiment B, aspirin (n = 10) or saline (n = 10) was given. Measurements and main results — DV-7028 significantly reduced the formation of coronary thrombi by 51% and attenuated the decrease in coronary blood flow without affecting systemic blood pressure and heart rate. There was a significant relationship between the thrombus weight and the decrease in coronary blood flow (pConclusion — The results suggest that 5-HT is involved in the platelet thrombosis and that inhibitory effect of DV-7028, a 5-HT2 receptor antagonist, on coronary thrombus formation was superior to that of aspirin.

This publication has 0 references indexed in Scilit: